GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12
TME Pharma welcomes this independent external validation of its therapeutic approach in glioblastoma by the German medical community
Covered in this story
Call it yourself
No calls on $TME yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Tencent Music Entertainment →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.